Clopidogrel Bisulfate PHARMALOGY,Active Pharmaceutical Ingredients,Description, Features, Details, biotech, materials, manufacturing, company, bulk, drugs, merck, process, active, ingredients, drug, excipient, tablet in India

Sitemap | Contact Us

Welcome To Taj Pharmaceuticals Ltd API

© 2004 - 2019 Taj Pharmaceuticals Limited . All rights reserved

clopidrogel bisulfate

India

Latin America/ Caribbean

Africa & Middle East

Asia

Russia

Europe

Clopidogrel Bisulfate Manufacturers in India Suppliers Clopidogrel Bisulfate Exporters Distributors Clopidogrel Bisulfate api active pharmaceuticals ingredients Clopidogrel Bisulfate manufacturers Side Effects bulk drugs raw material Clopidogrel Bisulfate companies Side Effects Importers Clopidogrel Bisulfate Clopidogrel Bisulfate Exporters Clopidogrel Bisulfate exporters FDA Clopidogrel Bisulfate DMF Symptoms Generic Taj Pharmaceuticals Ltd.

active pharmaceutical ingredients suppliers pharmaceutical Clopidogrel Bisulfate manufacturing pharmaceutical drugs pharmaceutical intermediates Clopidogrel Bisulfate pharmaceutical chemicals pharmaceutical raw materials Clopidogrel Bisulfate active pharmaceutical ingredients Clopidogrel Bisulfate committee active pharmaceutical ingredients manufacturer Clopidogrel Bisulfate Active Pharmaceutical Ingredients manufacturer Clopidogrel Bisulfate exporter drug ingredients pharmaceuticals

Pharmaceuticals API Manufacturer Clopidogrel Bisulfate, Clopidogrel Bisulfate manufacturer India, Clopidogrel Bisulfate product, Clopidogrel Bisulfate products, Api preparation, Certificate of Analysis API manufacturer product, Clopidogrel Bisulfate anti ulcer product, Certificate of Origin COA Clopidogrel Bisulfate COS Clopidogrel Bisulfate, pharmaceutical generic, pharmaceutical drug, medical, Clopidogrel Bisulfate pharma healthcare, pharma patents, contract MSDS manufacturing Trader Clopidogrel Bisulfate pharma, generic pharma, HCL pharma MSDS pharmaceutical products, pharmaceutical formulations, generic import API, Clopidogrel Bisulfate expectorant Pharmaceutical GMP Method of analysis formulations manufacturer, Clopidogrel Bisulfate DMF drug master file pharmaceutical Anti Cancer active ingredient exporter from India, pharma Clopidogrel Bisulfate ingredients, api, HIV Clopidogrel Bisulfate, tablets, capsules, syrup & protein Clopidogrel Bisulfate powder, GMP of Plant api nutraceuticals, gynec products, ortho ingredients in India, oncology products, Clopidogrel Bisulfate gastroenterology products, buy, sell orthopaedic product, who gmp, cGMP, US FDA, Clopidogrel Bisulfate WHO, UKMHRA Approval

	PRODUCT LIST
	Home
	API >>>
	Pharmaceuticals API List
	Chemicals
	Manufacturing
	Product Development
	Product Search
	Agro Chemicals
	Custom Pharma Services
	Contact Us

clopidrogel bisulfate

HOME >> API >> API List1 >> Clopidogrel Bisulfate >> Pharmalogy

PHARMALOGY
Clopidogrel Bisulfate CAS number 135046-48-9

Clopidogrel is a pro-drug whose action may be related to adenosine diphosphate (ADP) receptor on platelet cell membranes. The specific subtype of ADP receptor that clopidogrel binds is P2Y12 and is important in platelet aggregation and the cross-linking of platelets by fibrin

The blockade of this receptor inhibits platelet aggregation by blocking activation of the glycoprotein IIb/IIIa pathway. The IIb/IIIa complex functions as a receptor mainly for fibrinogen and vitronectin but also for fibronectin and von Willebrand factor. Activation of this receptor complex is the "final common pathway" for platelet aggregation, and is important in platelet aggregation, the cross-linking of platelets by fibrin.

Platelet inhibition can be demonstrated two hours after a single dose of oral clopidogrel, but the onset of action is slow, so that a loading-dose of 300-600 mg is usually administered.

Mechanism of Action

Clopidogrel is an inhibitor of platelet aggregation. A variety of drugs that inhibit platelet function have been shown to decrease morbid events in people with established cardiovascular atherosclerotic disease as evidenced by stroke or transient ischemic attacks, myocardial infarction, unstable angina or the need for vascular bypass or angioplasty. This indicates that platelets participate in the initiation and/or evolution of these events and that inhibiting them can reduce the event rate.

Information Associated with Product:

DRUG DESCRIPTION

DOSAGE

SIDE EFFECTS

PRECAUTIONS

INTERACTION

PHARMALOGY >>

CONSUMER INFORMATION

PDF DOWNLOAD

WORD DOCUMENT


Product Enquiry	Product Quotation	Sample Request	Place Your Order

Api Manufacturing At Taj

Acamprosate Calcium	Clomipramine Hcl	Alendronate Sodium	Clonazepam	Amitriptyline	Clopidogrel Bisulfate	Anastrozole	Danazol	Atomoxetine Hcl	Desloratadine	Balsalazide
Desmopressin Monoacetate	Bicalutamide	Divalproex Sodium	Budesonide	Dobutamine Hcl	Bupropion Hcl	Donepezil	Calcitonin	Dothiepin Hcl	Capecitabine	Entacapone
Carbamazepine	Eptifibatide	Carboplatin	Escitalopram HBr	Carisoprodol	Eszopiclone	Carvedilol	Finasteride	Cefuroxime Axetil	Flurbiprofen	Cisplatin
Fluticasone Propionate	Citalopram Hbr	Fluvoxamine Maleate	Fosphenytoin Sodium

Investor Relations Feedback Contact Worldwide Sitemap

© 2004 - 2019 Taj Pharmaceuticals Limited . All rights reserved
Note:-We are committed to helping you find the right answers to your questions and concerns. However, this web site is not intended to give investment advice, promote the use of Taj Pharmaceuticals Ltd products or provide information on which to base medical treatment. If you have questions regarding any Taj Pharmaceuticals Ltd product or are experiencing a medical emergency, please consult your health care provider.
Additionally, contact information on this web site cannot be used to report adverse drug events. If you are a physician, please follow the procedures required by your country's regulations. Please choose one of the given options to contact us and we will respond to your inquiry as quickly as possible.